BioNTech SE - ADR vs Cadence Design Systems Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Cadence Design Systems Inc trades at $326.51 (market cap $90.20B). The key difference: Cadence Design Systems Inc is far larger — about 3.9× BioNTech SE - ADR's market cap, and Cadence Design Systems Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | CDNS | |
|---|---|---|
Market Cap | $23.31B | $90.20B |
Sector | Health | Technology |
52-Week High | $119.34 | $416.39 |
52-Week Low | $83.89 | $265.66 |
Enterprise Value | $6.60B | $91.41B |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enable system-level analysis and verification solutions. Cadence's comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers, alongside secular digitalization of various end markets, benefits EDA vendors like Cadence.
Read more on CDNS →